NCT03743207

Brief Summary

Feeding intolerance is frequent among preterm infants in neonatal intensive care units (NICUs). Although there are many studies about enteral nutrition strategies and content in preterm infants, no evidence-based standards exist for the optimal milk temperature for preterm infants. Therefore, in this study the investigators aimed to examine the effects of feeding temperature and the possible morbidities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2014

Completed
4.5 years until next milestone

First Submitted

Initial submission to the registry

October 30, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

November 16, 2018

Completed
Last Updated

November 16, 2018

Status Verified

November 1, 2018

Enrollment Period

1.6 years

First QC Date

October 30, 2018

Last Update Submit

November 13, 2018

Conditions

Keywords

PrematurityEnteral nutritionFeeding toleranceTemperature

Outcome Measures

Primary Outcomes (1)

  • Gastric residual volume in mililitres after every feeding

    Gastric residual volume amount during the study

    through study completion, an average of 6 months

Secondary Outcomes (4)

  • Transition time to total enteral feeding

    through study completion, an average of 6 months

  • Daily weight gain

    through study completion, an average of 6 months

  • Need for anti reflux treatment

    through study completion, an average of 6 months

  • Body weight at discharge

    through study completion, an average of 6 months

Study Arms (2)

Room temperature

EXPERIMENTAL

All of the infants in neonatal intensive care units are used to be fed with milk at 22-24°C which is close to room temperature.

Other: Room temperature

Warmer temperature

EXPERIMENTAL

The investigators decided to feed the infants in this group with warmer milk at to examine the effects of feeding temperature.

Other: Warmer temperature

Interventions

These infants were fed with room temperature (22-24 °C) so that hypothesizing that they will have more feeding tolerance and therefore more co-existing morbidities.

Room temperature

Fifteen NICU mothers volunteered and expressed their milk for rapid measurement of freshly expressed breast milk. The mean (± SD) temperature of freshly expressed breast milk was found to be 33±1.5 °C in these preliminary measurements. Confirming this finding, the investigators decided to feed these infants with milk at 32 - 34 °C to examine the effects of feeding temperature and the possible comorbidities with a hypothesis that warmer feeding at the temperature of freshly expressed breast milk may be better physiologically.

Warmer temperature

Eligibility Criteria

Age1 Day - 30 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants born to birth weight of ≤1500 g
  • Infants born to gestational age of ≤ 34 weeks

You may not qualify if:

  • Genetic syndrome
  • Gastrointestinal system anomalies
  • Patients born small for their gestational age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University

Izmir, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Ozge Altun Koroglu, M.D.

    Ege University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The infants were randomly assigned using the last digit of their hospital identification number to two different groups with different feeding temperatures. Only the nurse giving the primary care was not blinded.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associated Professor, M.D.

Study Record Dates

First Submitted

October 30, 2018

First Posted

November 16, 2018

Study Start

October 1, 2012

Primary Completion

April 30, 2014

Study Completion

April 30, 2014

Last Updated

November 16, 2018

Record last verified: 2018-11

Locations